These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15768351)

  • 1. Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries.
    Reimer J; Schulte B; Castells X; Schafer I; Polywka S; Hedrich D; Wiessing L; Haasen C; Backmund M; Krausz M
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S373-8. PubMed ID: 15768351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection.
    Dore GJ; Thomas DL
    Semin Liver Dis; 2005 Feb; 25(1):18-32. PubMed ID: 15731995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.
    Doab A; Treloar C; Dore GJ
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S313-20. PubMed ID: 15768340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating hepatitis C virus infection in active substance users.
    Sylvestre DL
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S321-4. PubMed ID: 15768341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV.
    Kresina TF; Bruce RD; Cargill VA; Cheever LW
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S83-8. PubMed ID: 16265621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis C in drug addicts: access and treatment compliance].
    Sarmento E Castro R; Valente C; Ramos JP; Almeida JR; Marinho RT; Branco T; Andrade S; Macedo A
    Acta Med Port; 2011 Dec; 24 Suppl 2():483-92. PubMed ID: 22849938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities.
    Litwin AH; Soloway I; Gourevitch MN
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S339-45. PubMed ID: 15768345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical management of HIV-hepatitis C virus coinfection in injection drug users.
    Khalsa JH; Kresina T; Sherman K; Vocci F
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S1-6. PubMed ID: 16265605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Setting targets for universal access to HIV prevention, treatment and care for injecting drug users (IDUs): towards consensus and improved guidance.
    Donoghoe MC; Verster A; Pervilhac C; Williams P
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S5-14. PubMed ID: 18243681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating HCV services for drug users: a model to improve engagement and outcomes.
    Sylvestre DL; Zweben JE
    Int J Drug Policy; 2007 Oct; 18(5):406-10. PubMed ID: 17854729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
    Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
    Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C in injection drug users: It is time to treat.
    Grassi A; Ballardini G
    World J Gastroenterol; 2017 May; 23(20):3569-3571. PubMed ID: 28611509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
    Cullen W; Stanley J; Langton D; Kelly Y; Bury G
    Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
    J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxes in antiretroviral treatment for injecting drug users: access, adherence and structural barriers in Asia and the former Soviet Union.
    Wolfe D
    Int J Drug Policy; 2007 Aug; 18(4):246-54. PubMed ID: 17689372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.